TABLE 8.
No CMS (≤5) n (%) or median [IQR] | Mild total CMS score (6–10) n (%) or median [IQR] | Moderate total CMS score (>10) n (%) or median [IQR] | |
n (%) | 227 (96.6) | 7 (3.0) | 1 (0.4) |
Age (years) | 25 [22; 33] | 23 [22; 33] | 26 [26; 26] |
Ethnic group | |||
Aymara | 12 (5.3) | 1 (14.3) | 0 (0) |
Quechua | 215 (94.7) | 6 (85.7) | 1 (100) |
Residency in La Rinconada (years) | 3 [2; 5] | 3 [2; 4] | 6 [6; 6] |
Hematocrit (%) | 53 [49; 56] | 61 [57; 67]* | 60 [60; 60] |
SpO2 (%) | 83 [80; 85] | 80 [76; 83] | 83 [83; 83] |
Heart rate (bpm) | 90 [76; 97] | 90 [88; 94] | 93 [93; 93] |
Diastolic blood pressure (mm Hg) | 70 [70; 80] | 70 [70; 80] | 60 [60; 60] |
Systolic blood pressure (mm Hg) | 100 [100; 110] | 100 [100; 110] | 90 [90; 90] |
Breathlessness/palpitations | |||
0 | 180 (79.3) | 4 (57.1) | 0 (0) |
1 | 29 (12.8) | 1 (14.3) | 1 (100) |
2–3 | 18 (7.9) | 2 (28.6) | 0 (0) |
Sleep disturbance | |||
0 | 155 (68.3) | 7 (100) | 1 (100) |
1–3 | 72 (31.7) | 0 (0) | 0 (0) |
Cyanosis | |||
0 | 207 (91.2) | 4 (57.1)* | 0 (0) |
1–3 | 20 (8.8) | 3 (42.9)* | 1 (100) |
Dilatation of veins | |||
0 | 217 (95.6) | 7 (100) | 1 (100) |
1–3 | 10 (4.4) | 0 (0) | 0 (0) |
Paresthesia | |||
0 | 181 (79.7) | 6 (85.7) | 0 (0) |
1 | 37 (16.3) | 1 (14.3) | 1 (100) |
2–3 | 9 (4) | 0 (0) | 0 (0) |
Headache | |||
0 | 159 (70) | 6 (85.7) | 0 (0) |
1–3 | 68 (30) | 1 (14.3) | 1 (100) |
Tinnitus | |||
0 | 179 (78.9) | 7 (100) | 1 (100) |
1–3 | 48 (21.1) | 0 (0) | 0 (0) |
Hematocrit | |||
0 | 171 (75.3) | 0 (0)* | 0 (0) |
3 | 56 (24.7) | 7 (100)* | 1 (100) |
IQR, interquartile range; CMS, chronic mountain sickness; SpO2, pulse oxygen saturation. Scores of symptom severity were gathered together when the number of subjects per score was too small to allow statistical analysis. * Significantly different from subjects with no CMS (p < 0.05). No statistical comparison was performed with subject with moderate-severe total CMS score because of small sample size; no subject presented severe total CMS score.